Pharmacokinetics of Morphine and Its Metabolites in Infants and Young Children After Congenital Heart Surgery
Journal Title: The AAPS Journal - Year 2016, Vol 18, Issue 1
Abstract
The objective of this study was to characterize morphine glucuronidation in infants and children following cardiac surgery for possible treatment individualization in this population. Twenty children aged 3 days to 6 years, admitted to the cardiovascular intensive care unit after congenital heart surgery, received an intravenous (IV) loading dose of morphine (0.15 mg/kg) followed by subsequent intermittent IV bolus doses based on a validated pain scale. Plasma samples were collected over 6 h after the loading dose and randomly after follow-up doses to measure morphine and its major metabolite concentrations. A population pharmacokinetic model was developed with the non-linear mixed effects software NONMEM. Parent disposition was adequately described by a linear two-compartment model. Effect of growth (size and maturation) on morphine parameters was accounted for by allometric body weight-based models. An intermediate compartment with Emax model best characterized glucuronide concentrations. Glomerular filtration rate was identified as a significant predictor of glucuronide formation time delay and maximum concentrations. Clearance of morphine in children with congenital heart disease is comparable to that reported in children without cardiac abnormalities of similar age. Children 1–6 months of age need higher morphine doses per kilogram to achieve an area under concentration–time curve comparable to that in older children. Pediatric patients with renal failure receiving morphine therapy are at increased risk of developing opioid toxicity due to accumulation of morphine metabolites.
Authors and Affiliations
Mohammed H. Elkomy, David R. Drover, Kristi L. Glotzbach, Jeffery L. Galinkin, Adam Frymoyer, Felice Su, Gregory B. Hammer
Keywords
Related Articles
- EP ID EP680823
- DOI 10.1208/s12248-015-9826-5
- Views 34
- Downloads 0
Gender-Dependent Pharmacokinetics of Veratramine in Rats: In Vivo and In Vitro Evidence
The online version of this article (doi:10.1208/s12248-016-9870-9) contains supplementary material, which is available to authorized users.
Fish drug analysis—Phish-pharm: A searchable database of pharmacokinetics data in fish
Information about drug residues and pharmacokinetic parameters in aquatic species is relatively sparse. In addition, it is difficult to rapidly compare data between studies due to differences in experimental conditions,...
Sequential Bioequivalence Approaches for Parallel Designs
The online version of this article (doi:10.1208/s12248-014-9571-1) contains supplementary material, which is available to authorized users.
Ocular Drug Delivery
Ocular drug delivery has been a major challenge to pharmacologists and drug delivery scientists due to its unique anatomy and physiology. Static barriers (different layers of cornea, sclera, and retina including blood aq...
Absorption Enhancers: Applications and Advances
Absorption enhancers are functional excipients included in formulations to improve the absorption of a pharmacologically active drug. The term absorption enhancer usually refers to an agent whose function is to increase...